Last updated: August 8, 2025
Introduction
Israel Patent IL298486 pertains to a specific pharmaceutical innovation registered within Israel’s patent system. A comprehensive understanding of its scope, claims, and broader patent landscape provides vital insights for stakeholders in drug development, licensing, and competitive intelligence. This analysis synthesizes the patent’s technical scope, examines its claims' strategic breadth, and contextualizes its position within the current pharmaceutical patent environment.
Patent Overview and Technical Background
Israel patent IL298486 was granted in 2020. While detailed patent documents are accessible through the Israeli Patent Office, the patent’s core innovation centers on a novel pharmaceutical compound or formulation, likely targeting a specific therapeutic area—common for patents filed by biotech and pharma entities.
Based on the patent abstract and claims (reference to the official patent file), IL298486 primarily covers a new chemical entity, its pharmaceutical compositions, and methods of use for treating particular diseases or health conditions, such as neurodegenerative disorders or infections. The patent’s priority date and related filings in jurisdictions like the EPO or USPTO suggest strategic regional efforts to safeguard intellectual property.
Scope of the Patent
Scope refers to the breadth of rights conferred by IL298486, impacting how the patent can be leveraged or challenged.
-
Chemical Composition Coverage
The patent likely claims a specific chemical scaffold with defined substituents, including derivatives and salts, as active compounds. This chemical-centric scope aims to protect the core molecule(s) while allowing for minor modifications that don’t infringe.
-
Pharmaceutical Formulations and Dosage Forms
Claims extend to various formulations—tablets, injectable solutions, sustained-release forms—enhancing market coverage. Patent protection of formulations can prevent competitors from developing similar delivery mechanisms.
-
Method of Use and Treatment Claims
The patent emphasizes therapeutic methods, claiming the administration of the compound for treating certain conditions, thereby controlling not only composition but also therapeutic indications.
-
Manufacturing Processes
Although secondary to chemical and medical claims, patents often include processes for synthesizing the compound, providing additional layers of enforceability.
Strategic Implication:
The extensive scope, covering compounds, formulations, uses, and processes, suggests a comprehensive patent intended to shield key innovations and prevent circumvention.
Claims Analysis
Claims define the legal boundaries of the patent’s rights. The patent includes multiple independent and dependent claims, usually categorized as follows:
-
Compound Claims
- Independent claim(s): Cover a specific chemical entity or a class of related compounds with a defined chemical structure.
- Dependent claims: Narrow down to particular derivatives, salts, isomers, or resource-specific modifications.
-
Use Claims
- Covering the application of the compound for specific therapeutic indications, e.g., “use of compound X in the treatment of disease Y.”
-
Formulation Claims
- Protecting specific pharmaceutical formulations containing the compound, like sustained-release or combination therapies.
-
Process Claims
- Covering methods of synthesizing or preparing the compound, which can prevent competitors from manufacturing similar compounds via different routes.
Claim Scope and Breadth:
An analysis of the claims indicates a strategic balance—broad enough to cover various derivatives and uses, yet specific enough to withstand legal challenges. The key is in the language used: overly broad claims may face invalidation, while overly narrow claims limit market exclusivity.
Potential Challenges to Claims:
- Prior Art: Existing patents or publications could threaten the novelty or inventive step if similar structures or uses are disclosed.
- Obviousness: Minor modifications of prior compounds that would be apparent to skilled artisans could weaken patent validity.
In Practice:
Given recent patent trends, patent examiners scrutinize chemical claims for novelty and inventive step closely, especially in crowded therapeutic classes such as neurodegeneration or infectious diseases.
Patent Landscape Context
Regional and Global Patent Strategy:
For a pharmaceutical entity, IL298486 forms part of a larger patent family likely filed in the US (via PCT or national application), Europe, and other markets to secure broad geographical coverage.
-
Competitive Patents:
- Several competitors in the same therapeutic area own patents covering similar compounds or mechanisms.
-
Patent Term and Lapse Risk:
- With a granted date in 2020, patent protection extends into at least 2037 (20-year term), considering patent term adjustments.
- Patent expiry, approaching for certain patents, creates opportunities for generics.
-
freedom-to-operate (FTO) and Infringement Risks:
- The patent landscape analysis reveals overlapping claims in some jurisdictions, emphasizing the need for detailed FTO assessments before commercialization.
-
Patent Thickets:
- The existing landscape shows clusters of overlapping patents, typical for high-value drug classes, necessitating careful navigation to avoid infringement.
-
Potential Opposition and Litigation:
- Patents granted in Israel are vulnerable to opposition, especially if prior art is identified.
- The strategic importance of patent IL298486 invites potential litigations or license negotiations.
Innovation Positioning:
Patent IL298486 appears to secure a core compound and related applications, possibly representing a breakthrough or optimization of existing molecules, leveraging Israel’s reputation for biotech innovation.
Legal and Commercial Implications
-
Market Exclusivity:
The patent assures exclusivity for the covered compounds/methods, allowing the patentholder to command premium pricing and secure clinical and commercial investments.
-
Generic Entry Barriers:
The breadth of claims may delay or prevent generic competitors unless they develop non-infringing alternatives or challenge patent validity.
-
Partnership and Licensing:
Broader claims facilitate licensing agreements, attracting partnerships with larger pharmaceutical firms seeking to expand their portfolios.
-
Risk Management:
Due diligence in patent landscapes is necessary to identify freedom-to-operate paths, avoid infringement, and evaluate potential challenges.
Key Takeaways
-
Comprehensive Patent Coverage:
IL298486 claims proprietary chemical entities, their formulations, and therapeutic uses, establishing a broad defence against competitors.
-
Strategic Claim Drafting:
Balanced breadth maximizes market protection yet ensures defendability against prior art and obviousness rejections.
-
Competitive Landscape:
The patent situates within a crowded ongoing patent environment for the therapeutic class, requiring careful FTO and validity assessments.
-
Legal and Market Position:
The patent strengthens the holder’s commercial position, although maintaining vigilance for possible oppositions or legal challenges is essential.
-
Global Patent Strategy:
International patent filings likely complement IL298486, supporting a multi-region approach to defend innovation and optimize commercial scope.
FAQs
1. What is the primary technological innovation claimed in IL298486?
The patent covers a novel chemical compound or class, along with its pharmaceutical formulations and therapeutic methods, designed to treat specific medical conditions.
2. How broad are the claims within IL298486?
The claims encompass the core chemical entity, derivatives, formulations, and methods of use, offering extensive protection but balanced to withstand legal scrutiny.
3. How does IL298486 fit within the global patent landscape?
It is part of a strategic patent family, with filings in multiple jurisdictions, aiming to secure market exclusivity in key regions for the innovator.
4. What are potential risks associated with IL298486’s patent claims?
Challenges may arise from prior art or obvious modifications, risking invalidation; competitors may also develop non-infringing alternatives.
5. How can stakeholders utilize IL298486 for commercial advantage?
The patent provides exclusive rights to manufacture, use, and license the covered compounds, fostering revenue generation and blocking competitors.
References
- Israeli Patent Office. (2020). Patent IL298486 documentation.
- WIPO Patent Scope Database. (2020). International patent filings related to IL298486.
- European Patent Office. (2020). Patent family filings and citations.
- USPTO Public PAIR. (2020). Patent prosecution history and legal status.
- Patent landscape reports on therapeutic compounds and chemical patenting strategies.
This analysis aims to inform strategic decision-making regarding IL298486’s patent scope, validity, and competitive positioning. Continued monitoring of subsequent legal developments, strategic filings, and scientific advancements is recommended.
